Indianapolis, IN, United States of America

Michael LeRoy Phillips


Average Co-Inventor Count = 4.3

ph-index = 6

Forward Citations = 158(Granted Patents)


Company Filing History:


Years Active: 1987-2006

Loading Chart...
22 patents (USPTO):Explore Patents

Title: Michael LeRoy Phillips: Innovator in Pharmaceutical Science

Introduction

Michael LeRoy Phillips, based in Indianapolis, IN, is a distinguished inventor with a remarkable portfolio, holding 22 patents to his name. His contributions to the field of pharmaceutical science, particularly in inflammatory disease treatment, underscore his innovative spirit and dedication to advancing medical science.

Latest Patents

Among his most recent innovations are two notable patents. The first pertains to Indole sPLA2 inhibitors, detailing a class of novel acylsulfonamide substituted indole compounds designed to inhibit sPLA-mediated release of fatty acids. This breakthrough holds significant potential for treating inflammatory diseases, including septic shock. The second patent focuses on substituted tricyclics, which outlines a new class of tricyclic compounds aimed at the same therapeutic goal, addressing conditions such as septic shock by inhibiting the same release mechanism.

Career Highlights

Throughout his career, Michael has made significant strides in the pharmaceutical industry, particularly while working with Eli Lilly and Company. His dedication to research and development in pharmacology has been pivotal in creating solutions that have the potential to transform patient care.

Collaborations

Michael's success is also attributed to his strong collaborations with fellow researchers and innovators. Notably, he works alongside esteemed colleagues Jill A. Panetta and John Kevin Shadle, contributing to a dynamic environment of creativity and scientific exploration within Eli Lilly and Company.

Conclusion

Michael LeRoy Phillips exemplifies the essence of innovation in the pharmaceutical industry. With a robust patent portfolio and ongoing contributions to medical research, he continues to play a vital role in developing new treatments that address critical health challenges, particularly in inflammatory diseases. His work not only reflects his expertise but also shines a light on the importance of collaboration in driving forward advances in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…